The dimorphic fungus *Paracoccidioides brasiliensis* is known to be as a pathogenic agent of paracoccidioidomycosis disease. The clinical symptoms of this disease are pulmonary lesions and systemic generalized infections.\[[@ref1][@ref2]\] Pathogenesis study states that, the *P. brasiliensis* usually adhere to extracellular matrix proteins by means of its own surface molecules. The adhesion of the pathogenic microorganisms to host tissues is thought to be essential for initial colonization and further dissemination.\[[@ref3]\] As a consequence, this results a stage of severely hampered respiratory function due to infection, which is presumed to be acquired through inhalation of air-borne conidia produced by the mycelial form of fungus.\[[@ref4]\] Yet there is very little information available on the mechanisms underlying the pathogenesis of paracoccidioidomycosis or on the substance by which the fungus persists in the lungs and disseminates to other organs.\[[@ref5]\] A recent study has indicated that the ability of *P. brasiliensis* adherence property to host cells and tissues could play an important role in the establishment of infection.\[[@ref6]\] A 32-kDa protein of haloacid dehalogenase (HAD) superfamily of hydrolases present in the fungus is reported to be responsible for this.\[[@ref7]\] In addition to this, during the mycelium-to-yeast transition morphogenesis process of *P. brasiliensis* in the human host is considered as part of major metabolism involved in pathogenesis.\[[@ref8]\] For the treatment of the disease, drugs such as itraconazole, cotrimoxazole, trimethoprim, and amphotericin-B are commonly applied, also some of the drugs are in clinical trials. However, the current drugs are observed to be in-capable of reducing the infection and mortality rate in a satisfactory manner.\[[@ref9][@ref10]\] Therefore, there is an urgent need to identify novel drug molecules, as well as drug targets, by observing the high mortality rate and degree of pathogenicity of the fungus. The recent approach for new drug discovery is the use of genomics technology such as microarrays that provide a great platform to examine thousands of genes at a time.\[[@ref11][@ref12]\] This technology has tremendous potential in the field of biological annotation in health and disease. Microarray-based studies provide essential information for biomedical experiments, such as identification of disease-causing genes in malignancies and regulatory factors in cell cycle mechanism. This can identify genes for new and unique potential drug targets, predict drug responsiveness and ultimately lead to the development of prevention strategies of many diseases as described by many researchers.\[[@ref13][@ref14][@ref15][@ref16]\] Identification of disease-causing gene and constructing a gene regulatory networks in pathogen is essential. This can be viewed and extrapolated to the metabolic interaction of the pathogen. The knowledge about the network related to a specific disease or cellular metabolic process is of utmost importance for controlling them. However, the regulatory network re/construction is highly challenging and requires careful analysis of large sets of experimental data as well as through literature survey. A straight forward approach to reconstruct gene regulatory network is based on co-expression (CE) analysis of transcriptomic data popularly known as gene co-expression network (GCN), which can be performed *in-silico* by analyzing the data from cDNA microarrays.\[[@ref17]\] The HAD-like hydrolase superfamily constitutes a large group of proteins with diverse function and members are not only involved in the enzymatic cleavage carbon--halogen bonds (C--halogen), but also in a variety of other function.\[[@ref18][@ref19][@ref20]\] One of such function is adhesion of fungal pathogen *P. brasiliensis* with the cellular membrane, leads to pathogenesis as explained before.

Therefore, this study was performed to search for the co-expressed genes along with the HAD superfamily hydrolase gene in *P. brasiliensis*, which will lead to discover the gene expression network, from which potential drug candidate can be discovered. Also, attempts have been taken to analyze the CE network with the gene taken as references and annotation of the unknown gene by utilizing few existing software.

Subjects and Methods {#sec1-1}
====================

Retrieval of data {#sec2-1}
-----------------

The microarray expression data taken for the present *in-silico* analysis was retrieved from the gene expression omnibus (GEO) database of NCBI ([www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo/)), for mining purpose. In the GEO data search menu "*P. brasiliensis*" was searched, and the data set for the transition from spore to yeast was obtained. The researchers who submitted this data in GEO database has designed the experiment on expressed sequence tags (EST) of *P. brasiliensis* taken as probes for obtaining the signals of the intensity values. The GEO repository organization is basically divided into three levels as a platform, samples and series. A platform describes the list of elements on the array that may comprise of cDNAs, oligonucleotide probesets, ORFs, antibodies, etc., based on experiment. Each platform has a unique GEO accession number that starts with a GPL number. A sample describes the conditions under which an individual sample was handled. It also holds a unique and stable GEO accession number, which starts with GSM number. It contains a table describing hybridization details and a table of experiment result of that hybridization. Similarly, a series is a group of related samples. A GSE defines how and why the samples relate to each other. It contains tables describing extracted data, summary conclusions, etc. The GSM dataset contains only Cy3 labeled probes that were taken for all experiments along with their replica data. Also from the data sets, the value (Cy3/Cy5) was obtained along with the EST accession separately on the excel sheet.\[[@ref21]\]

Experimental design and analysis {#sec2-2}
--------------------------------

Since the experimental design is a very crucial step for the microarray data analysis, hence for the current study a comprehensive, concise and logical experimental design was developed to achieve the best co-expressed set of genes along with the HAD superfamily hydrolase gene. The data sets were then subjected to a filtering method using Coexpress tool.\[[@ref22]\] This is one of the sophisticated and user-friendly software tool for interactive comparison of construction profiles and building of the pair-wise gene or gene/miRNA co-expression matrixes. It is freely available can be downloaded from <http://bioinformatics.lu/CoExpress>. The software contains analytical pipeline for microarray data import, filtering large number of genes, normalization methods, prediction and validation of CE and network analysis. First from each data set the intensity of HAD superfamily gene was obtained and from the expression values mean, standard deviation, etc., were obtained. Filtering is then treated by submitting such data like maximum expression value, average construction value, standard deviation, etc., to facilitate the obtaining co-expressed genes with respect to the considered gene. The CE for an input matrix is calculated by the co-express software as following steps:

Create and fill with zeros for CE matrix M for storing the final resultFor each iteration i, while i ≤ number of runs (NR) perform the following actions:Randomly remove from the dataset percentage removed dataset % of the experimentsCalculate CE matrix for the reduced dataset, LAll values of L, which are on an absolute scale less than threshold during bootstrapping are set to 0Add L to M: M = M + LBack to step 2.Calculate the average CE in M by, M = M/NR.

Further, these co-expressed genes obtained for all data sets were visualized in the Cytoscape 2.8.3 software tool and network construction was observed ([www.cytoscape.org](http://www.cytoscape.org)). Further annotation was performed in the common genes present in the network by performing a BLAST X search with the EST to identify the protein (<http://blast.ncbi.nlm.nih.gov/Blast.cgi?>). Also, those EST which no match was translated by the TRANSEQ module of EMBOSS software ([www.ebi.ac.uk/Tools/st/emboss_transeq](http://www.ebi.ac.uk/Tools/st/emboss_transeq)). Then PSI-BLAST was performed to each protein sequence against the human genome to obtain the homology. Further the nonhomologous genes in the selected network were annotated by the SMART domain prediction server (smart.embl-heidelberg.de/).

Results {#sec1-2}
=======

The GEO data set entitled "transcriptome analysis of *P. brasiliensis* cells undergoing the mycelium-to-yeast transition" was considered for the study.\[[@ref20]\] Microarray data in the experiment has been derived with RNA hybridization from fungal culture at 5, 10, 24, 48, 72 and 120 h respectively in a temperature range from 26°C to 37°C, and the RNA obtained from the original mycelial has taken as reference (t = 0 h). Each time point was analyzed with four independent hybridizations, labeled as "Exp 1" and "Exp 2" with each chip carried two replicas were available for each time point in the data. For our study the data set GPL 2780 was selected from GEO, having a single platform and contains 48 samples (GSM files). In the current work, total 24 sample files were obtained for each Cy3 labeled probe in replica and experiments. The four Cy3 labeled group of data were named as CY3_E1_R1 (for experiment 1 and replica 1), CY3_E2_R1 (for experiment 2 and replica 1), CY3_E1_R2 (for experiment 1 and replica 2) and CY3_E2_R2 (for experiment 2 and replica 2) as described in [Table 1](#T1){ref-type="table"}.

###### 

Experimental datasets considered for the data analysis

![](JPBS-7-212-g001)

Co-expression analysis {#sec2-3}
----------------------

With the selected GSM files an *in-silico* CE analysis was performed. Preliminary analysis about the mean and standard deviation value of the HAD superfamily hydrolase gene was obtained \[[Figure 1](#F1){ref-type="fig"}\].

![The expression value of haloacid dehalogenase superfamily hydrolase expressed sequence tags in different data set of consideration cy3_e1_r1 (standard deviation = 0.61, mean = −0.067), cy3_e2_r1 (standard deviation = 0.659, mean = −0.09), cy3_e1_r2 (standard deviation = 0.17, mean = 0.05), cy3_e2_r2 (standard = 0.34, mean = 0.129)](JPBS-7-212-g002){#F1}

This value was also carefully observed during setting of gene filtering parameter. The mean of expression values from all time periods was obtained that represents the average expression of the genes. The original dataset contains 4340 genes, but after removal of EST, that does bear any expression value, the final input of each data set was made as 3229 × 6 matrix containing row as EST and expression value (Cy3/Cy5) in different time intervals as columns. For filtration purpose following parameters are considered \[[Table 2](#T2){ref-type="table"}\].

###### 

Parameters for different datasets considered for gene filtration purpose

![](JPBS-7-212-g003)

After filtration of the data, Pearson correlation measure was selected with correlation power 1 and filtering threshold 0.9 for CE calculation purpose by Coexpress tool. Further, the CE calculation was bootstrapped 1000 times for validation purpose. The result of CE was obtained for all data sets and the interacting EST is given in [Table 3](#T3){ref-type="table"}.

###### 

The results of the individual co-expressed genes (EST codes) for each data set
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Network construction and analysis of gene annotation {#sec2-4}
----------------------------------------------------

From the computed CE matrix obtained from the CE tool, the data was fed to Cytoscape tool to observe the network architecture. The network displays the CE pattern of 23 different common genes that were expressed in all the considered data sets along with the test gene HAD superfamily hydrolases \[[Figure 2](#F2){ref-type="fig"}\].

![The common network architecture of the genes that are co-express with haloacid dehalogenase superfamily hydrolase expressed sequence tags (ID BQ491758) when observed in Cytoscape tool](JPBS-7-212-g005){#F2}

Further annotation of the EST sequences was performed by the BLASTX tool to key out the protein present in the organism. The result contains the major hits proteins, which are \~100% similarity with *P. brasiliensis* Pb03 organism. Of 23, only 9 proteins do not have significant matches in BLAST X search with 8 proteins are found to be nonhomologous to human by protein PSI BLAST search \[[Table 4](#T4){ref-type="table"}\].

###### 

Annotation details about the common co-expressed genes
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Discussion {#sec1-3}
==========

In the present analysis, the non-receipt of a homologous sequence of ESTs indicates these might have genes; whose function has not been identified. Also, the selected pathway contains the genes linked to the spermidine synthase, which is found to be an essential drug target in many organisms as protozoa, as well as pathogenic fungi.\[[@ref23][@ref24][@ref25]\] Again the spermidine synthase is also found to be an essential protein in dimorphism of the pathogenic fungi, which is related to the pathogenesis, has been observed earlier.\[[@ref26][@ref27][@ref28]\] Although the proteins share homology with human, but this is found to be nonessential in case of human, as searched from the Database of essential gene for *Homo sapiens* available at <http://www.essentialgene.org/>. The three-dimensional structure of spermidine synthase of *P. brasiliensis* Pb03 was also not present in the Protein Data Bank. Hence, the result obtained here provides an opportunity for structural modeling and robust system biology study to find out about the novel drug target by considering the pathway. Moreover, the pathway obtained in this work will lead to discovery of suitable potential drugs against the *P. brasiliensis* Pb03 with novel drug targets that have been predicted by the gene expression analysis. The genes listed in the table do not show homology with the human, therefore, could be considered for the development of new antifungal drug targets. The SMART based domain analysis indicates about the sequences also contains the domains, which are essential in function \[[Table 5](#T5){ref-type="table"}\].

###### 

Annotation of the EST by in-silico translation followed by SMART domain analysis software (only proteins available in the selected network are given)
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Since *P. brasiliensis* pb03 infection is a medical problem, the prediction of new drug targets from sequence information is of great importance. The genes that are commonly co-expressed in the dimorphic fungi *P. brasiliensis* Pb03 could be considered for drug target for paracoccidioidomycosis therapy by inhibiting the adhesion process during the establishment of pathogenesis. Previously, the gene CE analysis at a particular physiological stage in case of Mycobacterium has revealed the scope for identification of novel drug targets.\[[@ref29]\] Similarly, the CE protein network has also been used in an integrated manner with metabolic pathways for identification of targets in the cancer therapeutics research.\[[@ref30][@ref31]\]

Our work suggested that *in-silico* analysis is a suitable strategy for discovering co-expressed genes with HAD superfamily hydrolases. Therefore, this analysis also provides a valuable resource of information regarding a gene responding during the transformation of mycelium-to-yeast transition in pathogenic fungi *P. brasiliensis*. We analyzed the expression profile of 4340 genes present in 4 selected data sets, among which 23 genes were found to be co-expressed under all conditions of experimental concern. Annotating these genes and homology search predicts that many of these genes having strong potential for the development of anti-fungal therapy, as these genes play a significant role in the fungal metabolism during human infection. Gene CE and functional analysis of the *P. brasiliensis* Pb03 genes described in this work may be used for further study for morphogenesis of the pathogen. In conclusion, the knowledge of the predicted genes *of P. brasiliensis* pb03 will most likely facilitate the development of new therapeutics against paracoccidioidomycosis disease as well as other related mycosis.
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